CA2044511A1 - Pharmaceutical resorption-improved somatostatin compositions, their preparation and use - Google Patents

Pharmaceutical resorption-improved somatostatin compositions, their preparation and use

Info

Publication number
CA2044511A1
CA2044511A1 CA002044511A CA2044511A CA2044511A1 CA 2044511 A1 CA2044511 A1 CA 2044511A1 CA 002044511 A CA002044511 A CA 002044511A CA 2044511 A CA2044511 A CA 2044511A CA 2044511 A1 CA2044511 A1 CA 2044511A1
Authority
CA
Canada
Prior art keywords
somatostatin
composition according
acid
formula
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002044511A
Other languages
English (en)
French (fr)
Inventor
Gerd Fricker
Jacky Vonderscher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2044511A1 publication Critical patent/CA2044511A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002044511A 1990-06-15 1991-06-13 Pharmaceutical resorption-improved somatostatin compositions, their preparation and use Abandoned CA2044511A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909013448A GB9013448D0 (en) 1990-06-15 1990-06-15 Pharmaceutical resorption-improved somatostatin compositions,their preparation and use
GB9103448 1991-02-19

Publications (1)

Publication Number Publication Date
CA2044511A1 true CA2044511A1 (en) 1991-12-16

Family

ID=10677720

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002044511A Abandoned CA2044511A1 (en) 1990-06-15 1991-06-13 Pharmaceutical resorption-improved somatostatin compositions, their preparation and use

Country Status (21)

Country Link
EP (1) EP0462071B1 (enExample)
JP (1) JPH04230223A (enExample)
KR (1) KR920000323A (enExample)
AU (1) AU7833191A (enExample)
CA (1) CA2044511A1 (enExample)
CH (1) CH683069A5 (enExample)
DE (1) DE4119062A1 (enExample)
ES (1) ES2067906T3 (enExample)
FI (1) FI912868L (enExample)
FR (1) FR2663227B1 (enExample)
GB (2) GB9013448D0 (enExample)
HU (1) HUT59007A (enExample)
IE (1) IE912010A1 (enExample)
IL (1) IL98477A0 (enExample)
IT (1) IT1297205B1 (enExample)
LU (1) LU87952A1 (enExample)
NO (1) NO912271L (enExample)
NZ (1) NZ238522A (enExample)
PT (1) PT97964A (enExample)
TW (1) TW226332B (enExample)
ZA (1) ZA914583B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11400159B2 (en) 2008-09-17 2022-08-02 Amryt Endo, Inc. Pharmaceutical compositions and related methods of delivery
US11510963B1 (en) 2015-02-03 2022-11-29 Amryt Endo, Inc. Method of treating diseases
US11890316B2 (en) 2020-12-28 2024-02-06 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9203769D0 (en) * 1992-02-21 1992-04-08 Sandoz Ltd Improvements in or relating to organic compounds
US5578324A (en) * 1993-07-30 1996-11-26 Teijin Limited Peptide proteinaceous drug nasal powder composition
GB9417524D0 (en) * 1994-08-31 1994-10-19 Cortecs Ltd Pharmaceutical compositions
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
BR0110208A (pt) * 2000-04-19 2003-01-28 Borody Thomas J Composições e terapias para distúrbios associados com hiperlipidemia
US20030083241A1 (en) * 2001-11-01 2003-05-01 Young Charles W. Use of somatostatin receptor agonists in the treatment of human disorders of sleep hypoxia and oxygen deprivation
PT2275103E (pt) 2005-11-21 2014-07-24 Novartis Ag Inibidores de mtor para o tratamento de tumores endócrinos
US8318657B2 (en) * 2005-12-01 2012-11-27 Flinders Technologies Pty Ltd. Methods and compositions for preventing and/or treating pancreatitis
GB0817969D0 (en) 2008-10-01 2008-11-05 Axcess Ltd Pharmaceutical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
HU198626B (en) * 1986-05-27 1989-11-28 Sandoz Ag Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient
JPS632932A (ja) * 1986-06-23 1988-01-07 Teijin Ltd 経鼻投与用粉末状組成物
HU203204B (en) * 1987-09-15 1991-06-28 Sandoz Ag Process for producing suppository containing calcitonin and taurocholic acid

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11400159B2 (en) 2008-09-17 2022-08-02 Amryt Endo, Inc. Pharmaceutical compositions and related methods of delivery
US11969471B2 (en) 2008-09-17 2024-04-30 Amryt Endo, Inc. Pharmaceutical compositions and related methods of delivery
US11986529B2 (en) 2008-09-17 2024-05-21 Amryt Endo, Inc. Pharmaceutical compositions and related methods of delivery
US11510963B1 (en) 2015-02-03 2022-11-29 Amryt Endo, Inc. Method of treating diseases
US11857595B2 (en) 2015-02-03 2024-01-02 Amryt Endo, Inc. Method of treating diseases
US12246054B2 (en) 2015-02-03 2025-03-11 Amryt Endo, Inc. Method of treating diseases
US12251418B2 (en) 2015-02-03 2025-03-18 Amryt Endo, Inc. Method of treating diseases
US11890316B2 (en) 2020-12-28 2024-02-06 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Also Published As

Publication number Publication date
TW226332B (enExample) 1994-07-11
EP0462071B1 (en) 1995-02-01
FR2663227A1 (fr) 1991-12-20
FI912868A7 (fi) 1991-12-16
FR2663227B1 (fr) 1995-04-28
IE912010A1 (en) 1991-12-18
CH683069A5 (de) 1994-01-14
ITRM910430A1 (it) 1992-12-17
JPH04230223A (ja) 1992-08-19
PT97964A (pt) 1992-03-31
GB2244918B (en) 1994-06-15
DE4119062A1 (de) 1991-12-19
NZ238522A (en) 1993-10-26
ES2067906T3 (es) 1995-04-01
LU87952A1 (fr) 1993-01-15
HU911849D0 (en) 1991-12-30
ITRM910430A0 (it) 1991-06-17
AU7833191A (en) 1992-01-02
EP0462071A1 (en) 1991-12-18
IT1297205B1 (it) 1999-08-03
FI912868L (fi) 1991-12-16
GB2244918A (en) 1991-12-18
GB9013448D0 (en) 1990-08-08
GB9112509D0 (en) 1991-07-31
IL98477A0 (en) 1992-07-15
HUT59007A (en) 1992-04-28
ZA914583B (en) 1993-02-24
NO912271D0 (no) 1991-06-13
FI912868A0 (fi) 1991-06-13
KR920000323A (ko) 1992-01-29
NO912271L (no) 1991-12-16

Similar Documents

Publication Publication Date Title
JP5042312B2 (ja) Ｈｇｈを含む経口送達用医薬組成物
RU2198679C2 (ru) Препараты для лечения метаболического синдрома, содержащие гормон роста человека в комбинации с ингибитором синтеза кортизола
US5547938A (en) Therapeutic agent for digestive tract diseases using glicentin
JPH11508606A (ja) 経口用ペプチド薬剤
JP2003519667A (ja) トリグリセリドレベルの調節および脂質異常血症の治療のためのエキセンジンおよびそのアゴニストの使用
JP2003528135A (ja) 糖尿病のランゲルハンス島シグナリングの改善方法及びその防止方法
HU208635B (en) Process for production of stabilized medical preparatives containing fibroblast growing factor
KR20060034298A (ko) 골관절염에 대한 칼시토닌의 용도
CA2044511A1 (en) Pharmaceutical resorption-improved somatostatin compositions, their preparation and use
EP0163723A1 (en) DDAVP ANTIDIURETIQUE AND METHOD OF USING THE SAME.
US5393738A (en) Pharmaceutical compositions containing octreotide and excipients for oral or rectal administration
JP2809707B2 (ja) 関節炎の処置
WO2006126673A1 (ja) 組み合わせによる糖尿病治療薬
JP2001508769A (ja) アレンドロン酸塩及び胃排出を促進する薬剤を含有する医薬組成物
EP0471761B1 (en) Use of a GnRHanalog for the manufacture of a medicament for the treatment of motility disorders
JPH05148154A (ja) 生理活性ポリペプチド含有製剤
CN115463208B (zh) 一种口服降糖组合物
JP3091518B2 (ja) 骨粗鬆症予防治療剤
FR2668933A1 (fr) Composition pharmaceutique a base de somatostatine.
HUSSAR New drugs
JPH01246223A (ja) 潰瘍治療剤
JPH10218767A (ja) 骨疾患治療剤
CZ298999A3 (cs) Výroba léčiva, kombinovaný therapeutický prostředek a směs a kit obsahující inhibitor syntézy kortisolu a růstový hormon

Legal Events

Date Code Title Description
FZDE Discontinued